IM Cannabis consolidates shares for renewed Nasdaq trading
The company adjusts its share structure to meet exchange listing requirements while maintaining its existing ticker symbol and operational focus in Israel and Germany.
See the latest news and media coverage for IMC. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical cannabis company
imcannabis.comLast updated
In short: IMC sold its European operations, strengthened its balance sheet, and regained Nasdaq minimum bid price compliance.
The company adjusts its share structure to meet exchange listing requirements while maintaining its existing ticker symbol and operational focus in Israel and Germany.
The company executes a 30-for-1 share consolidation to raise its stock price above the $1.00 minimum bid price requirement by late August 2026.
H1 revenue fell to $16.3M from $25.2M, with a net loss of $6.9M for the six months ended June 30, 2026.
The transaction is expected to reduce debt by CAD$10.5 million and streamline operations.
IM Cannabis (NASDAQ:IMCC) completes sale of IMC Holdings to Slil, retaining Israeli operations and expecting improved balance ...
IM Cannabis signs a non-binding letter of intent to buy a majority stake in Space Defense Innovations, expanding its portfolio beyond medical cannabis into technology.
IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC), a medical cannabis company with operations in Israel and Germany, is pleased to announce that it...
"Q1 2025 is a clear inflection point for IMC," said Oren Shuster, Chief Executive Officer of IMC. "Achieving net profitability and an 87% improvement in...
Track IMC and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to IMC and other trending companies.